New technology for the delivery of peptide-based T-cell vaccines for tumour immunotherapy

用于肿瘤免疫治疗的基于肽的 T 细胞疫苗的新技术

• 批准号: LP0883541
• 负责人: Prof Patrick Perlmutter
• 金额: $ 59.03万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-07-01 至 2010-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0883541
• 关键词: New; technology; delivery; peptide; based

This project is dedicated to finding simple methods for vaccinating humans and animals against a wide variety of cancers. Should this be achieved millions of Australians will be protected from the devastating consequences of cancer. Consequently there will be great benefits socially, medically and economically.

该项目致力于寻找简单的方法，为人类和动物接种疫苗，预防多种癌症。如果能实现这一目标，数百万澳大利亚人将免受癌症的毁灭性后果。因此，在社会、医疗和经济方面都将产生巨大的效益。